Return to search

Novo Holdings leads Series C round for Exscientia

UK-based Exscientia, an artificial intelligence drug discovery company, has raised $60 million in Series C financing.

UK-based Exscientia, an artificial intelligence drug discovery company, has raised $60 million in Series C financing. Novo Holdings led the round.

Source: Press Release